| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702688 | Urologic Oncology: Seminars and Original Investigations | 2017 | 6 Pages |
Abstract
To our knowledge, this is the first systematic evaluation of the incidence, predictors, and prognostic effect of ascites in metastatic pRCC. Malignant ascites is a common manifestation of metastatic pRCC and is associated with a shorter overall survival. An elevated platelet-lymphocyte ratio predicts a higher risk of developing malignant ascites.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Abhinav M.D., Meet M.D., Julia C. M.S., M.P.H., Louis S. M.D., Daniel M.D., Maria J. M.D., Ramaprasad M.D., Ph.D.,